Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: 4DMedical, Bardy Diagnostics, Beyond Air, Merit Medical, Orteq Sports Medicine, Philips, Smart Medical Systems, United Imaging.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Activstyle, Adapthealth, Astrazeneca, Bio-Techne, Cerus, Echelon Diagnostics, Emed Technologies, Genscript Biotech Europe, Histoindex, IBM Watson Health, Koru Medical Systems, Leica Biosystems, Mauna Kea Technologies, Mesa Labs, Repro Med Systems, Seti, Siemens Healthineers, Skywater Solara Medical Supplies, St Robotics, Velano Vascular, Vizient.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Freenome, Lucence, Oncolytics Biotech, Orteq Sports Medicine.

Med-tech firms raising money in public or private financings, including: Davita, Digirad, Oncology Analytics, Stereotaxis, Transmedics Group, Viacyte.

New hires and promotions in the med-tech industry, including: Biofourmis, Delcath Systems, Freenome, Micron Medical, Progenity, Renovacare.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abivax, Akeso, Algernon, Alnylam, Aurinia, Cytrx, Expression, Hansa, Kala, Neurobo, Novaremed, Orphazyme, Qurient, Rockwell, Sino, Takeda, Zealand.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Beigene, Carna Bio, Chi-Med, Debiopharm, Elekta, Hikma, Hitgen, Ipsen, Junshi Bio, Kaiku, Lysogene, Novasep, Oncodesign, Pfizer, Pharmacyte, Poxel, Qualigen, Regeneron, Ritter, Sanofi, Seranovo, Shionogi, Takara, Tavotek, Tetra Therapeutics.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Acadia, Aeglea, Alnylam, Arena, Argenx, Atara, Clene, Dermavant, Durect, Glenmark, GSK, Immunocore, Innovent, Janssen, Lilly, Mesoblast, Novavax, Oncolytics, Regeneron, Sanofi, Synairgen, Teva.

Biopharmas raising money in public or private financings, including: Accure, Arvelle, Avidity, Biolinerx, Gamida Cell, Generation Bio, Insitro, Nanoviricides, OSE Immunotherapeutics, Portage Biotech, Poxel, Preveceutical, Sterna, Tollys, Tricida, Windtree.

New hires and promotions in the biopharma industry, including: Anchiano, Applied, Elevar, Hyloris, Medivir, Orion, Springworks, Vor.